Healthcare provider profile · identity verified

Sarah A Mayfield, MD

Pediatric Medicine · BOWLING GREEN, KY · NPI 1992732820

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	284	65
Levothyroxine Sodium	Levothyroxine Sodium	222	49
Losartan Potassium	Losartan Potassium	161	40
Omeprazole	Omeprazole	154	32
Atenolol	Atenolol	141	28
Amlodipine Besylate	Amlodipine Besylate	137	34
Gabapentin	Gabapentin	133	45
Lisinopril	Lisinopril	133	31
Rosuvastatin Calcium	Rosuvastatin Calcium	131	33
Simvastatin	Simvastatin	112	30
Duloxetine Hcl	Duloxetine Hcl	106	28
Pantoprazole Sodium	Pantoprazole Sodium	102	24
Metformin Hcl	Metformin Hcl	97	24
Furosemide	Furosemide	91	24
Trazodone Hcl	Trazodone Hcl	83	23
Sertraline Hcl	Sertraline Hcl	76	17
Spironolactone	Spironolactone	68	16
Eliquis	Apixaban	61	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	15
Metformin Hcl Er	Metformin Hcl	59	19
Montelukast Sodium	Montelukast Sodium	58	15
Ozempic	Semaglutide	56	14
Mirtazapine	Mirtazapine	54	19
Metoprolol Tartrate	Metoprolol Tartrate	53	16
Meloxicam	Meloxicam	49	11
Bupropion Hcl Sr	Bupropion Hcl	48	11
Pioglitazone Hcl	Pioglitazone Hcl	48	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	46	14
Celecoxib	Celecoxib	46	suppressed
Potassium Chloride	Potassium Chloride	46	11
Alendronate Sodium	Alendronate Sodium	45	12
Amitriptyline Hcl	Amitriptyline Hcl	45	12
Fluticasone Propionate	Fluticasone Propionate	45	16
Buspirone Hcl	Buspirone Hcl	44	14
Metoprolol Succinate	Metoprolol Succinate	40	15
Carvedilol	Carvedilol	39	12
Escitalopram Oxalate	Escitalopram Oxalate	37	12
Prednisone	Prednisone	37	16
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	suppressed
Nifedipine Er	Nifedipine	35	suppressed
Clonazepam	Clonazepam	33	suppressed
Farxiga	Dapagliflozin Propanediol	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	12
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Allopurinol	Allopurinol	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Glyburide	Glyburide	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Estradiol	Estradiol	24	suppressed
Azithromycin	Azithromycin	23	17
Hydrochlorothiazide	Hydrochlorothiazide	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Levofloxacin	Levofloxacin	20	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Lactulose	Lactulose	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Temazepam	Temazepam	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Fluconazole	Fluconazole	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Topiramate	Topiramate	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error